HORMONES and SPORT Proof of the Effect of Testosterone on Skeletal

Total Page:16

File Type:pdf, Size:1020Kb

HORMONES and SPORT Proof of the Effect of Testosterone on Skeletal 27 HORMONES AND SPORT Proof of the effect of testosterone on skeletal muscle S Bhasin, L Woodhouse and T W Storer1 Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R Drew University of Medicine and Science, Los Angeles, California 90059, USA 1Laboratory for Exercise Sciences, El Camino College, Torrance, California, USA (Requests for offprints should be addressed to S Bhasin, Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R Drew University of Medicine and Science, Los Angeles, California 90059, USA) Abstract In spite of the widespread abuse of androgenic steroids improve physical function and health-related quality of by athletes and recreational body-builders, the effects of life, and reduce the risk of falls and disability in older men these agents on athletic performance and physical func- or those with chronic illness. Testosterone increases maxi- tion remain poorly understood. Experimentally induced mal voluntary strength in a dose-dependent manner and androgen deficiency is associated with a loss of fat-free thus might improve performance in power-lifting events. mass; conversely, physiologic testosterone replacement of However, testosterone has not been shown to improve healthy, androgen-deficient men increases fat-free mass performance in endurance events. The mechanisms by and muscle protein synthesis. Testosterone supplemen- which testosterone increases muscle mass are not known, tation of HIV-infected men with low testosterone levels but probably involve alterations in the expression of and of older men with normally low testosterone concen- multiple muscle growth regulators. trations also increases muscle mass. However, we do not Journal of Endocrinology (2001) 170, 27–38 know whether physiologic testosterone replacement can The abuse of androgenic steroids by athletes and the increase muscle mass and strength; however, the academic proposed anabolic applications of these agents in sarco- community decried their use, citing lack of verifiable penia (loss of muscle mass and strength) associated with evidence (Wilson 1988, Bardin 1996, Casaburi et al. aging or chronic illness is based on the premise that these 1996b). The historical aspects of the use of androgenic/ agents increase muscle mass and improve measures of anabolic steroids have been extensively reviewed (Wilson skeletal muscle performance, and that androgen-induced 1988, Bardin 1996). Although their use is most common changes in skeletal muscle performance translate into among weight-lifters and heavy throwers, almost all types improvements in athletic performance and health-related of athletes whose event requires explosive strength, in- outcomes (Fig. 1). The premise remains unsubstantiated. cluding football players, swimmers and track and field There is agreement that testosterone supplementation athletes, have been known to use steroids. Their use has increases muscle mass and maximal voluntary strength in a spread to high-school athletes and to amateur body- variety of clinical and experimental paradigms (Tenover builders. Disqualification of highly celebrated athletes 1992, Urban et al. 1995, Bhasin et al. 1996, 1997, Brodsky in recent years has focused substantial media attention on et al. 1996, Katznelson et al. 1996, Wang et al. 1996, 2000, this issue. Synder et al. 2000), but we do not know whether Considerable debate has raged in the academic com- testosterone improves athletic performance or health- munity for five decades on whether androgenic steroids related outcomes, and whether beneficial effects of andro- had anabolic effects on the muscle, due in part to the gens can be achieved without significant long-term shortcomings of previous studies; several reviews have adverse effects. discussed these study design issues (Wilson 1988, Bardin Opinion as to the effects of testosterone on the muscle 1996). For instance, many of the studies that examined the in healthy eugonadal men has been enormously contro- effect of androgenic steroids were neither blinded nor versial for more than five decades (Wilson 1988, Bardin randomized. Some studies included competitive athletes, 1996, Casaburi et al. 1996b). The athletes who abuse whose desire to win at any cost prevent them from androgenic steroids believe fervently that these drugs complying with a standardized regimen of diet and Journal of Endocrinology (2001) 170, 27–38 Online version via http://www.endocrinology.org 0022–0795/01/0170–027 2001 Society for Endocrinology Printed in Great Britain Downloaded from Bioscientifica.com at 09/26/2021 10:22:26PM via free access 28 S BHASIN and others · Effect of testosterone on skeletal muscle Figure 1 Rationale for the abuse of androgenic steroids by athletes and their potential application as anabolic therapy for sarcopenia associated with old age and chronic illness. This is based on the premise that these agents induce alterations in muscle gene expression that result in increased muscle mass and improved muscle performance. It is further assumed that increased muscle mass and performance will translate into improved physical function, athletic performance and health-related outcomes. Although androgenic steroids have been shown to increase muscle mass and maximal voluntary strength, their effects on physical function, health-related outcomes and athletic performance have not been rigorously studied. The heavy arrow indicates areas of certainty, and lighter arrows indicate areas of uncertainty. exercise. Nutritional intake was not controlled in many of eugonadal men (Katznelson et al. 1996, 1998). Mauras the studies; changes in energy and protein intake might et al. (1998) have reported that experimental suppression of have had independent effects on nitrogen balance. Exer- serum testosterone by administration of a gonadotropin- cise stimulus was not standardized and, in some studies, the releasing hormone (GnRH) agonist analog in healthy participants were allowed to exercise ad libitum. Therefore, young men is associated with a significant reduction in the effects of androgen administration could not be fat-free mass, an increase in fat mass, and a decrease separated from the effects of resistance exercise training. in fractional muscle protein synthesis. An age-associated Most of the studies performed before the 1980s used decline in serum testosterone concentrations correlates relatively small doses of androgenic steroids, equivalent with decreased appendicular muscle mass and reduced to or less than the replacement dose of testosterone used lower extremity strength in white and in African- for the treatment of androgen-deficient men. In con- American men (Morley et al. 1993, 1997). trast, athletes use supraphysiological doses of androgenic steroids. Because of these problems of study design, the results of these previous studies were inconclusive. With Effects of physiologic testosterone replacement in the advent of magnetic resonance imaging and more healthy, young hypogonadal men refined methods for the assessment of body composition, it has become possible to detect small changes in muscle Testosterone replacement increases nitrogen retention in volume and fat-free mass with a greater degree of precision castrated males of several animal species (Kochakian et al. and accuracy than was feasible before. Consequently, 1950), eunuchoidal men, boys before puberty, and women studies published in the past 6 years by a number of groups (Kenyon et al. 1940). Several recent studies have re- have now established that testosterone supplementation examined the effects of testosterone on body composition does increase muscle mass and strength (Bhasin et al. 1996, and muscle mass in hypogonadal men in more detail. We Brodsky et al. 1996, Katznelson et al. 1996, Wang et al. administered 100 mg testosterone enanthate intramuscu- 1996, 2000, Snyder et al. 2000). larly weekly for 10 weeks to seven hypogonadal men after a10–12 week period of androgen withdrawal (Bhasin et al. 1997). Testosterone replacement was associated with a A reduction in serum testosterone is associated 4·50·6kg(P=0·005) increase in body weight because with decreased fat-free mass ofa5·00·8kg(P=0·004) increase in fat-free mass, estimated from underwater weight, whereas body fat Healthy, hypogonadal men have lower fat-free mass and did not change. Similar increases in fat-free mass were higher fat mass compared with those of age-matched observed using the deuterium water dilution method. Arm Journal of Endocrinology (2001) 170, 27–38 www.endocrinology.org Downloaded from Bioscientifica.com at 09/26/2021 10:22:26PM via free access Effect of testosterone on skeletal muscle · S BHASIN and others 29 Table 1 Effects of testosterone replacement on body composition in hypogonadal men Age Testosterone Change in Change in Change in (years) regimen fat-free mass fat mass muscle strength Study Bhasin et al. 19–47 Testosterone enanthate 5·00·7kg No change in fat mass +223% (1997) 100 mg weekly for (9·91·4%) by underwater weight 10 weeks increase by underwater and D2O weight and D2O Katznelson 22–69 Testosterone enanthate 72% increase by 144% decrease in Not measured et al. (1996) or cypionate 100 mg bioelectrical impedance percent body fat, weekly for 18 months 134% decrease in subcutaneous fat Brodsky et al. 33–57 Testosterone cypionate 15% increase by DXA 11% decrease in fat Not measured (1996) 3 mg/kg every 2 weeks scan mass for 6 months Wang et al. 19–60 Sublingual testosterone 0·9 kg (2%) increase by No change in fat mass No change in arm press, (1996) 5 mg three times a day DXA scan 8·7 kg increase in for 6 months leg-press Snyder et al. 22–78 Transdermal 3·13·3 kg increase by No change in fat mass No change in isokinetic (2000) testosterone patch for DXA scan strength of knee 12–36 months extension Wang et al. 19–68 Testosterone gel 2·70·3 kg increase by 1 kg decrease in fat Leg-press strength (2000) (50–100 mg/day) DXA scan mass increased by 11–13 kg 180 days D2O, deuterium water. and leg muscle cross-sectional areas, assessed by magnetic Bardin 1996, Casaburi et al. 1996b). We conducted a resonance imaging, increased significantly. Substantial in- placebo-controlled, double-blind, randomized clinical trial creases in muscle strength were also noted after treatment.
Recommended publications
  • Comparison of the Effects of High Dose Testosterone and 19-Nortestosterone to a Replacement Dose of Testosterone on Strength and Body Composition in Normal Men
    J. Steroid Biochem. Molec. Biol. Vol. 40, No. 4-6, pp. 607~12, 1991 0960-0760/91 $3.00 + 0.00 Printed in Great Britain Pergamon Press plc COMPARISON OF THE EFFECTS OF HIGH DOSE TESTOSTERONE AND 19-NORTESTOSTERONE TO A REPLACEMENT DOSE OF TESTOSTERONE ON STRENGTH AND BODY COMPOSITION IN NORMAL MEN KARL E. FRIEDL,* JOSEPH R. DETTORI, CHARLES J. HANNAN JR, TROY H. PATIENCE and STEPHENR. PLYMATE Exercise Physiology Division, U.S. Army Research Institute of Environmental Medicine, Natick, MA and Department of Clinical Investigation, Madigan Army Medical Center, Tacoma, WA, U.S.A. Summary--We examined the extent to which supraphysiological doses of androgen can modify body composition and strength in normally virilized men. In doubly blind tests, 30 healthy young men received testosterone enanthate (TE) or 19-nortestosterone decanoate (ND), at 100mg/wk or 300mg/wk for 6 weeks. The TE-100mg/wk group served as replacement dose comparison, maintaining pretreatment serum testosterone levels, while keeping all subjects blinded to treatment, particularly through reduction in testicular volumes. Isokinetic strength measurements were made for the biceps brachii and quadriceps femoris muscle groups before treatment and 2-3 days after the 6th injection. Small improvements were noted in all groups but the changes were highly variable; a trend to greater and more consistent strength gain occurred in the TE-300mg/wk group. There was no change in weight for TE-100 mg/wk but an average gain of 3 kg in each of the other groups. No changes in 4 skinfold thicknesses or in estimated percent body fat were observed.
    [Show full text]
  • Testosterone, Injectable
    Clinical Criteria Subject: Testosterone, Injectable Document #: ING-CC-0026 Publish Date: 06/10/201909/23/2019 Status: ReviewedRevised Last Review Date: 03/18/201908/16/2019 Table of Contents Overview Coding References Clinical criteria Document history Overview This document addresses indications for the intramuscular (IM) and subcutaneous (SC) administration of testosterone injectables for the treatment of hormone deficient conditions. The following testosterone injection agents are included: • Testosterone cypionate intramuscular: Depo-Testosterone, generic testosterone cypionate • Testosterone enanthate: o Intramuscular: generic testosterone enanthate o Subcutaneous: Xyosted (auto-injector) • Testosterone undecanoate intramuscular: Aveed Testosterone is an androgen hormone responsible for normal growth and development of male sex characteristics. In certain medical conditions such as hypogonadism, the endogenous level of testosterone falls below normal levels. Primary hypogonadism includes conditions such as testicular failure due to cryptorchidism, bilateral torsion, orchitis, or vanishing testis syndrome; bilateral orchidectomy; and inborn errors in the biosynthesis of testosterone. Secondary hypogonadism, also called hypogonadotropic hypogonadism includes conditions such as gonadotropin-releasing hormone (GnRH) deficiency or pituitary-hypothalamic injury resulting from tumors, trauma, surgery, or radiation. In 2015, the Endocrine Society added the following amended recommendations: • Men with metabolic syndrome, who were previously unexamined by the 2010 Endocrine Society Clinical Practice Guidelines, may benefit from testosterone replacement therapy (TRT) based on improvements in biometrics and insulin sensitivity. Effects of TRT on similar endpoints in men with type 2 diabetes mellitus remain unclear; • Effects of TRT on erectile function, even in men refractory to phosphodiesterase type 5 inhibitors, and on quality of life in men with erectile dysfunction remain inconclusive (Seftel, 2015).
    [Show full text]
  • Pharmacology/Therapeutics II Block III Lectures 2013-14
    Pharmacology/Therapeutics II Block III Lectures 2013‐14 66. Hypothalamic/pituitary Hormones ‐ Rana 67. Estrogens and Progesterone I ‐ Rana 68. Estrogens and Progesterone II ‐ Rana 69. Androgens ‐ Rana 70. Thyroid/Anti‐Thyroid Drugs – Patel 71. Calcium Metabolism – Patel 72. Adrenocorticosterioids and Antagonists – Clipstone 73. Diabetes Drugs I – Clipstone 74. Diabetes Drugs II ‐ Clipstone Pharmacology & Therapeutics Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones, March 20, 2014 Lecture Ajay Rana, Ph.D. Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones Date: Thursday, March 20, 2014-8:30 AM Reading Assignment: Katzung, Chapter 37 Key Concepts and Learning Objectives To review the physiology of neuroendocrine regulation To discuss the use neuroendocrine agents for the treatment of representative neuroendocrine disorders: growth hormone deficiency/excess, infertility, hyperprolactinemia Drugs discussed Growth Hormone Deficiency: . Recombinant hGH . Synthetic GHRH, Recombinant IGF-1 Growth Hormone Excess: . Somatostatin analogue . GH receptor antagonist . Dopamine receptor agonist Infertility and other endocrine related disorders: . Human menopausal and recombinant gonadotropins . GnRH agonists as activators . GnRH agonists as inhibitors . GnRH receptor antagonists Hyperprolactinemia: . Dopamine receptor agonists 1 Pharmacology & Therapeutics Neuroendocrine Pharmacology: Hypothalamic and Pituitary Hormones, March 20, 2014 Lecture Ajay Rana, Ph.D. 1. Overview of Neuroendocrine Systems The neuroendocrine
    [Show full text]
  • The Combined Cardiac Effect of the Anabolic Steroid, Nandrolone And
    ù1. v -¿. rlc) 77.- *n*hi.rnool oowol,ù*o ffi"/fu -lo *rn*(o fii'o fio¿o¿¿, /v&"ùún lonno **al cooaiæe';¿vfl"- oã. Benjamin D. Phillis, B.Sc. (Hons) Phatmacology Depattment of Clinical & Experimental Pharmacology Ftome Rd. , Medical School Noth Adelaide Univetsity ADEIAIDE SA 5OOO û.)r.'-*hr/7enveltîù Foremost, I would like to thank my two supervisors for the direction that they have given this ptojecr. To Rod, for his unfailing troubleshooting abiJity and to Jenny fot her advice and ability to add scientific rigour' Many thanks to Michael Adams for his technical assistance and especially fot performing the surgery for the ischaemia-reperfusion projects and for his willingness to work late nights and public holidays. Lastly I would like to thank my v¡ife for her extreme patience during the tumult of the last 5 years. Her love, suppoït, patience and undetstanding have been invaluable in this endeavout. Beniamin D. Phillis Octobet,2005 ADE,I-AIDE ii T*(¿t of Ao,t",tù DECI.ARATION I ACKNOWLEDGEMENTS il TABLE OF CONTENTS UI ABBREVIATIONS x ABSTRACT )ilr CÉIAPTER t-l Inttoduction 1-1 1.1 Background 1,-1, 1.2What ate anabolic stetoids? 7-1 1,3 General pharmacology of Anabolic steroids t-2 '1,-2 1.3.1 Genomic effects of anabolic steroids 1.3.2 Non-genomic effects of anabolic steroids 1-3 1.4 Clinical use of AS 1.-4 1.5 Patterns of AS abuse 1.-4 1.5.1 Steroid abuse by athletes 1.-+ 1.5.2 Stetoid abuse by sedentary teenagers r-6 1.5.3 Prevalence of abuse 1-6 1.5.4 Abuse ptevalence in Australia 1.-9 1.6 Cardiotoxicity of anabolic steroids r-9 1.6.1 Reduced cotonary flow 1.-1.1, 1,.6.2 Dtect myocatdial eff ects 1-1 5 1.6.3 Hypertension 1-21 1.7 Difficulties associated with anabolic steroid research 1.-24 1-25 1.8 The polydrug abuse Phenomenon 1.9 The pharmacology of cocaine 1-26 1.10 Pteparations 1-28 1-29 1.11 Metabolism lll 1-30 1.
    [Show full text]
  • Testosterone Enanthate Other Names: DELATESTRYL®
    For the Patient: Testosterone Enanthate Other names: DELATESTRYL® • Testosterone enanthate (tes-TOS-te-rone en-AN-thate) is a male hormone that is used to treat breast cancer in women. It is a clear liquid that is injected into a muscle. • A blood test may be taken from time to time. The dose and timing of your testosterone enanthate may be changed based on the test results and/or other side effects. • Tell your doctor if you have thyroid problems as testosterone enanthate may interact with thyroid tests (thyroid function is not affected). Tell your doctor if you have high cholesterol as testosterone enanthate may increase or decrease cholesterol. • Store testosterone enanthate at room temperature and out of the reach of children. • Use testosterone enanthate exactly as directed by your doctor. Make sure you understand the directions and feel comfortable with the injections. • Use a different site for each injection. Check with your nurse or doctor to find out which sites on your body can be used for injections. • Use each syringe once only to avoid infection. Place used syringes in a rigid plastic container with a lid. Discard the container as instructed by your treatment centre. Keep out of reach of children. • Other drugs such as warfarin (COUMADIN®) may interact with testosterone enanthate. Tell your doctor if you are taking this/these or any other drugs as you may need extra blood tests or your dose may need to be changed. Check with your doctor or pharmacist before you start taking any new drugs. • The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of testosterone enanthate.
    [Show full text]
  • Testosterone C2270-A
    Drug and Biologic Coverage Criteria Effective Date: 04/12/2018 Last P&T Approval/Version: 07/28/2021 Next Review Due By: 08/2022 Policy Number: C2270-A Testosterone PRODUCTS AFFECTED ANDROID (methyltestosterone), ANDRODERM (testosterone topical), ANDROGEL (testosterone topical), AVEED (testosterone undecanoate), AXIRON (testosterone topical), DELATESTRYL (testosterone enanthate), DEPO-TESTOSTERONE (testosterone cypionate) FORTEST (testosterone topical), JATENZO (testosterone undeconoate), METHITEST (methyltestosterone), NATESTO (testosterone nasal gel),TESTIM* (testosterone topical), TESTOPEL (testosterone implant), TESTRED* (methyltestosterone), VOGELXO* (testosterone topical), XYOSTED (testosterone enanthate) COVERAGE POLICY Coverage for services, procedures, medical devices, and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Coverage Guideline must be read in its entirety to determine coverage eligibility, if any. This Coverage Guideline provides information related to coverage determinations only and does not imply that a service or treatment is clinically appropriate or inappropriate. The provider and the member are responsible for all decisions regarding the appropriateness of care. Providers should provide Molina Healthcare complete medical rationale when requesting any exceptions to these guidelines Documentation Requirements: Molina Healthcare reserves the right to require that additional documentation be made available as part of its coverage determination; quality improvement;
    [Show full text]
  • Hepatotoxic and Cardiotoxic Effects of Testosterone Enanthate Abuse on Adult Male Albino Rats
    Al-Azhar Med. J.( Medicine). Vol. 50(2), April, 2021, 1335 - 1348 DOI: 10.12816/amj.2021.158480 https://amj.journals.ekb.eg/article_158480.html HEPATOTOXIC AND CARDIOTOXIC EFFECTS OF TESTOSTERONE ENANTHATE ABUSE ON ADULT MALE ALBINO RATS By Mohamed Abd El-Aziz El-Gendy, Fouad Helmy El-Dabbah, Ashraf Ibrahim Hassan and Naser Abd El-Naby Awad* Departments of Forensic Medicine & Clinical Toxicology and Pathology*, Al-Azhar Faculty of Medicine, Egypt E-mail: [email protected] ABSTRACT Background: Anabolic androgenic steroids (AASs) represent a group of synthetic derivatives of testosterone created to maximize anabolic effects and minimize the androgenic ones. Athletes use anabolic androgenic steroids (AAS) to enhance performance regardless of the health risk they may impact in some persons. Objective: To study the histopathological and biochemical changes that could occur on liver and cardiac muscle after administration of doping dose (supraphysiological dose) of testosterone enanthate (one of AAS). Materials and Methods: One hundred (100) male albino rats were included in the present study and divided into six groups. Group (1a); negative control group, Group (1b) positive control group treated with therapeutic dose of testosterone Enanthate (10 mg /Kg body weight intramuscular / I.M weekly for 12 weeks), group (2) was treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M for 4 weeks), group (3) was treated with treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 8 weeks), group (4) treated with doping dose of testosterone enanthate (60 mg /Kg body weight / I.M weekly for 12 weeks), group (5a) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M/ weekly for 12 weeks followed by 2 weeks of treatment discontinuation) , group (5b) treated with doping dose of testosterone enanthate (60 mg /Kg body weight/ I.M weekly for 12 weeks followed by 4 weeks of treatment discontinuation).
    [Show full text]
  • Effects of Nandrolone Stimulation on Testosterone Biosynthesis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Archivio istituzionale della ricerca - Università di Palermo ORIGINAL RESEARCH ARTICLE 1385 JournalJournal ofof Cellular Effects of Nandrolone Physiology Stimulation on Testosterone Biosynthesis in Leydig Cells CRISTOFORO POMARA,1,2* ROSARIO BARONE,3,4 ANTONELLA MARINO GAMMAZZA,3,4 CLAUDIA SANGIORGI,4 FULVIO BARONE,1,5 ALESSANDRO PITRUZZELLA,3,6 NICOLA LOCOROTONDO,7 FRANCESCA DI GAUDIO,8 MONICA SALERNO,1 FRANCESCA MAGLIETTA,9 ANTONIO LUCIANO SARNI,1 VALENTINA DI FELICE,4 3,4 1 FRANCESCO CAPPELLO, AND EMANUELA TURILLAZZI 1Department of Forensic Pathology, University of Foggia, Foggia, Italy 2Department of Anatomy, University of Malta, Msida, Malta 3Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy 4Department of Experimental Biomedicine and Clinical Neurosciences (BioNeC), University of Palermo, Palermo, Italy 5Department of Radiology, Scientific Institute Hospital “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG), Italy 6Department of Neuroscience, Mental Health and Sense Organs (Nesmos), Sapienza University of Rome, Rome, Italy 7Locorotondo Labs srl, Palermo, Italy 8Department of Pathobiology and Medical Biotechnology, University of Palermo, Palermo, Italy 9Department of Forensic Pathology, Sapienza University of Rome, Rome, Italy Anabolic androgenic steroids (AAS) are among the drugs most used by athletes for improving physical performance, as well as for aesthetic purposes. A number of papers have showed the side effects of AAS in different organs and tissues. For example, AAS are known to suppress gonadotropin-releasing hormone, luteinizing hormone, and follicle-stimulating hormone. This study investigates the effects of nandrolone on testosterone biosynthesis in Leydig cells using various methods, including mass spectrometry, western blotting, confocal microscopy and quantitative real-time PCR.
    [Show full text]
  • Determination of Testosterone Esters in Serum by Liquid Chromatography – Tandem Mass Spectrometry (LC-MS-MS)
    Department of Physics, Chemistry and Biology Final Thesis Determination of testosterone esters in serum by liquid chromatography – tandem mass spectrometry (LC-MS-MS) Erica Törnvall Final Thesis performed at National Board of Forensic Medicine 2010-06-03 LITH-IFM-EX--10/2263--SE Department of Physics, Chemistry and Biology Linköping University 581 83 Linköping, Sweden 1 Department of Physics, Chemistry and Biology Determination of testosterone esters in serum by liquid chromatography – tandem mass spectrometry (LC-MS-MS) Erica Törnvall Final Thesis performed at National Board of Forensic Medicine 2010-06-03 Supervisors Yvonne Lood Martin Josefsson Examiner Roger Sävenhed 2 Avdelning, institution Datum Division, Department Date 2010-06-03 Chemistry Department of Physics, Chemistry and Biology Linköping University Språk Rapporttyp ISBN Language Report category Svenska/Swedish Licentiatavhandling ISRN: LITH-IFM-EX--10/2263--SE Engelska/English Examensarbete _________________________________________________________________ C-uppsats D-uppsats Serietitel och serienummer ISSN ________________ Övrig rapport Title of series, numbering ______________________________ _____________ URL för elektronisk version Titel Title Determination of testosterone esters in serum by liquid chromatography – tandem mass spectrometry (LC-MS-MS) Författare Author Erica Törnvall Sammanfattning Abstract Anabolic androgenic steroids are testosterone and its derivates. Testosterone is the most important naturally existing sex hormone for men and is used for its anabolic effects providing increased muscle mass. Testosterone is taken orally or by intramuscular injection in its ester form and are available illegally in different forms of esters. Anabolic androgenic steroids are today analyzed only in urine. To differentiate between the human natural testosterone and exogenous supply the quote natural testosterone and epitestosterone is used.
    [Show full text]
  • Hepatotoxicity Associated with Illicit Use of Anabolic Androgenic Steroids in Doping
    Eur opean Rev iew for Med ical and Pharmacol ogical Sci ences 2017; 21 (1 Suppl): 7-16 Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping R. SOLIMINI, M.C. ROTOLO, L. MASTROBATTISTA, C. MORTALI, A. MINUTILLO, S. PICHINI, R. PACIFICI, I. PALMI Department of Therapeutic Research and Medicines Evaluation, Drug Abuse and Doping Unit, Istituto Superiore di Sanità, Rome, Italy Abstract. – Anabolic Androgenic Steroids Since then , several synthetic analogs of testos - (AAS) abuse and misuse is nowadays a harmful terone, known as Anabolic Androgenic Steroids habit involving both professional or recreational (AAS) or designer steroids (e.g . methyltestos - athletes, as well as general population. AAS are also frequently present in over-the-counter di - terone in 1935 , nandrolone in 1950 and 1953, etary supplements without being declared in the testosterone esters from mid-1950s, stanozolol list of ingredients, leaving consumers unaware and oxymetholone in 1959 , oxandrolone in 1962) of the risks of adverse effects. Indeed, health have been produced in the attempt to minimize risks of AAS consumption in pharmaceutical the androgenic effects and improve the anabolic preparations or dietary complements seem still ones 1,2,7-9 . However , a successful complete sepa - underestimated and under-reported. The variety of complications due to AAS misuse involves ration of the anabolic and the androgenic proper - cardiovascular, central nervous, musculoskeletal ties has never been realized in the synthetic de - and genitourinary systems of both males and fe - rivatives of testosterone 1,2,10,11 . Among those, nan - males; psychiatric and behavioral effects, dam - drolone was the first compound which showed a ages to metabolic system, skin and mainly liver.
    [Show full text]
  • Intramuscular Testosterone
    Intramuscular Testosterone 1 Intramuscular (IM) testosterone products marketed in Canada* DIN Manufacturer Product Active Ingredient Strength Testosterone 00029246 Valeant Delatestryl 200 mg/ml Enanthate Testosterone 00030783 Pfizer Depo-Testosterone 100mg/ml Cypionate * Other products have been approved but are not currently being marketed.1 Confirm that ongoing use of testosterone is indicated Approved indication for IM testosterone therapy2: androgen replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Off-label uses3: hormone therapy for transgender males, sexual disorder, weight gain, others. 1 Potential alternatives for IM testosterone* DIN Product Strength Dosage Form Manufacturer 02322498 PMS-Testosterone 40mg oral capsule PMS 02421186 Taro-Testosterone 40 mg oral capsule TAR 02239653 2.5 mg/24 h transdermal Androderm ALL 02239653 5 mg/24 h patch 02249499 1% (12.5 mg/actuation) 02245345 Androgel 1% (25 mg/pack) transdermal gel BGP 02245346 1% (50 mg/pack) 02463792 Taro-Testosterone 1% (25 mg/pack) transdermal gel TAR 02463806 Gel 1% (50 mg/pack) 02280248 Testim 1% (50 mg/tube) transdermal gel PAL 02450550 Natesto 4.5% (5.5 mg/actuation) nasal gel ACP * All doses expressed as amount of testosterone delivered Considerations when choosing an alternate form of testosterone: GENERAL dosage recommendations for androgen deficiency o Testosterone enanthate or cypionate4,5: various doses and frequencies may be used. general: 75 -100 mg IM/subcutaneous (SC) every week . doses may range from 50 to 200 mg . frequencies may range from every 1 week to every 3-4 weeks (though the longer the interval, the greater the fluctuation in concentrations5 ) o Testosterone transdermal gel 1% 50 mg – 100 mg4,6 applied daily to an area of skin that will be covered.
    [Show full text]
  • The Effects of Anabolic-Androgenic Steroids on Aging in Bodybuilders
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1-1-2003 The effects of anabolic-androgenic steroids on aging in bodybuilders Barbara Szlendakova Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Recommended Citation Szlendakova, Barbara, "The effects of anabolic-androgenic steroids on aging in bodybuilders" (2003). Retrospective Theses and Dissertations. 20055. https://lib.dr.iastate.edu/rtd/20055 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. The effects of anabolic-androgenic steroids on aging in bodybuilders by Barbara Szlendakova A thesis submitted to the graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Genetics Program of Study Committee: Eric Henderson (Maj or Professor) Fredric Janzen Douglas King Iowa State University Ames, Iowa 2003 11 Graduate College Iowa State University This is to certify that the master's thesis of Barbara Szlendakova has met the requirements of Iowa State University Signatures have been redacted for privacy iii TABLE OF CONTENTS ABSTRACT v1 CHAPTER 1. INTRODUCTION 1 Cellular Aging and Telomeres 1 What are anabolic-androgenic steroids 2 Structure of anabolic-androgenic steroids 4 How do steroids work? 5 Modes of anabolic-androgenic steroid use 8 Oral preparations 8 Effectiveness of oral steroids 8 lnjectible preparations 12 Oil-based preparations 12 Water-based preparations 13 Transdermal preparations 15 Anabolic-androgenic steroid use 15 Medical uses of anabolic-androgenic steroids 16 Side effects of steroid abuse 17 CHAPTER 2.
    [Show full text]